CD24 and familial pancreatic carcinoma: However, when comparing the proteomics study of CD24+ pancreatic cancer cells enriched from patient material [58] with our data generated from two human pancreatic cancer cell lines, there is a clear match at the level of pathways differentially regulated in CSCs and tumor bulk cells.